Skip to main content
Journal of Family Medicine and Primary Care logoLink to Journal of Family Medicine and Primary Care
. 2022 Oct 31;11(10):6615. doi: 10.4103/2249-4863.359352

Retraction: Role of methyle blue in the management of mild, moderate and severe COVID-19 disease

PMCID: PMC9810929  PMID: 36618143

The Letter to Editor titled “Role of methyle blue in the management of mild, moderate and severe COVID-19 disease” published in Journal of Family Medicine and Primary Care, on pages 812-814, Issue 2, Volume 11, 2022,[1] is being retracted because the editors found certain ethical concerns. Such publications violate the editorial policy of Journal of Family Medicine and Primary Care, which follows best practice guidelines given by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE) mentioned on the Information for Authors and as codified in the signed statements made by the authors regarding the copyright of their work.

This article has been retracted on request of the Editor-in-Chief and the editorial board of the journal.

Editor-in-Chief:

Journal of Family Medicine and Primary Care

Reference

  • 1.Bawaskar, Himmatrao Saluba;Bawaskar, Pramodini Himmatrao. Role of methyle blue in the management of mild, moderate and severe COVID-19 disease. Journal of Family Medicine and Primary Care. 2022;11(2):812–814. doi: 10.4103/jfmpc.jfmpc_2071_21. February. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Journal of Family Medicine and Primary Care are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES